Augustin Lecler1, Loïc Duron2, Mathieu Zmuda3, Kevin Zuber4, Olivier Bergès2, Marc Putterman5, Julien Savatovsky2, Laure Fournier6,7. 1. Department of Neuroradiology, Foundation Adolphe de Rothschild Hospital, 25 rue Manin, 75019, Paris, France. alecler@for.paris. 2. Department of Neuroradiology, Foundation Adolphe de Rothschild Hospital, 25 rue Manin, 75019, Paris, France. 3. Department of Orbitopalpebral Surgery, Foundation Adolphe de Rothschild Hospital, Paris, France. 4. Department of Clinical Research, Foundation Adolphe de Rothschild Hospital, Paris, France. 5. Department of Pathology, Necker-Enfants Malades Hospital, APHP, Paris, France. 6. Université de Paris, PARCC, INSERM, F-75015, Paris, France. 7. Radiology Department, AP-HP, Hôpital europeen Georges Pompidou, F-75015, Paris, France.
Abstract
OBJECTIVES: To determine the diagnostic accuracy of MRI intravoxel incoherent motion (IVIM) when characterizing orbital lesions, which is challenging due to a wide range of locations and histologic types. METHODS: This IRB-approved prospective single-center study enrolled participants presenting with an orbital lesion undergoing a 3-T MRI prior to surgery from December 2015 to July 2019. An IVIM sequence with 15 b values ranging from 0 to 2000 s/mm2 was performed. Two neuroradiologists, blinded to clinical data, individually analyzed morphological MRIs. They drew one region of interest inside each orbital lesion, providing apparent diffusion coefficient (ADC), true diffusion coefficient (D), perfusion fraction (f), and pseudodiffusion coefficient (D*) values. T test, Mann-Whitney U test, and receiver operating characteristic curve analyses were performed to discriminate between orbital lesions and to determine the diagnostic accuracy of the IVIM parameters. RESULTS: One hundred fifty-six participants (84 women and 72 men, mean age 54.4 ± 17.5 years) with 167 orbital lesions (98/167 [59%] benign lesions including 54 orbital inflammations and 69/167 [41%] malignant lesions including 32 lymphomas) were included in the study. ADC and D were significantly lower in malignant than in benign lesions: 0.8 × 10-3 mm2/s [0.45] versus 1.04 × 10-3 mm2/s [0.33], p < 0.001, and 0.75 × 10-3 mm2/s [0.40] versus 0.98 × 10-3 mm2/s [0.42], p < 0.001, respectively. D* was significantly higher in malignant lesions than in benign ones: 12.8 × 10-3 mm2/s [20.17] versus 7.52 × 10-3 mm2/s [7.57], p = 0.005. Area under curve was of 0.73, 0.74, 0.72, and 0.81 for ADC, D, D*, and a combination of D, f, and D*, respectively. CONCLUSIONS: Our study showed that IVIM might help better characterize orbital lesions. KEY POINTS: • Intravoxel incoherent motion (IVIM) helps clinicians to assess patients with orbital lesions. • Intravoxel incoherent motion (IVIM) helps clinicians to characterize orbital lymphoma versus orbital inflammation. • Management of patients becomes more appropriate.
OBJECTIVES: To determine the diagnostic accuracy of MRI intravoxel incoherent motion (IVIM) when characterizing orbital lesions, which is challenging due to a wide range of locations and histologic types. METHODS: This IRB-approved prospective single-center study enrolled participants presenting with an orbital lesion undergoing a 3-T MRI prior to surgery from December 2015 to July 2019. An IVIM sequence with 15 b values ranging from 0 to 2000 s/mm2 was performed. Two neuroradiologists, blinded to clinical data, individually analyzed morphological MRIs. They drew one region of interest inside each orbital lesion, providing apparent diffusion coefficient (ADC), true diffusion coefficient (D), perfusion fraction (f), and pseudodiffusion coefficient (D*) values. T test, Mann-Whitney U test, and receiver operating characteristic curve analyses were performed to discriminate between orbital lesions and to determine the diagnostic accuracy of the IVIM parameters. RESULTS: One hundred fifty-six participants (84 women and 72 men, mean age 54.4 ± 17.5 years) with 167 orbital lesions (98/167 [59%] benign lesions including 54 orbital inflammations and 69/167 [41%] malignant lesions including 32 lymphomas) were included in the study. ADC and D were significantly lower in malignant than in benign lesions: 0.8 × 10-3 mm2/s [0.45] versus 1.04 × 10-3 mm2/s [0.33], p < 0.001, and 0.75 × 10-3 mm2/s [0.40] versus 0.98 × 10-3 mm2/s [0.42], p < 0.001, respectively. D* was significantly higher in malignant lesions than in benign ones: 12.8 × 10-3 mm2/s [20.17] versus 7.52 × 10-3 mm2/s [7.57], p = 0.005. Area under curve was of 0.73, 0.74, 0.72, and 0.81 for ADC, D, D*, and a combination of D, f, and D*, respectively. CONCLUSIONS: Our study showed that IVIM might help better characterize orbital lesions. KEY POINTS: • Intravoxel incoherent motion (IVIM) helps clinicians to assess patients with orbital lesions. • Intravoxel incoherent motion (IVIM) helps clinicians to characterize orbital lymphoma versus orbital inflammation. • Management of patients becomes more appropriate.
Entities:
Keywords:
Diffusion MRI; Magnetic resonance imaging; Orbital neoplasms
Authors: J Ben Soussan; R Deschamps; J C Sadik; J Savatovsky; L Deschamps; M Puttermann; M Zmuda; F Heran; O Galatoire; H Picard; A Lecler Journal: Eur Radiol Date: 2016-07-19 Impact factor: 5.315
Authors: A Lecler; M Boucenna; F Lafitte; P Koskas; E Nau; P V Jacomet; O Galatoire; S Morax; M Putterman; F Mann; F Héran; J C Sadik; H Picard; O Bergès Journal: Eur Radiol Date: 2016-06-07 Impact factor: 5.315
Authors: K Haradome; H Haradome; Y Usui; S Ueda; T C Kwee; K Saito; K Tokuuye; J Matsubayashi; T Nagao; H Goto Journal: AJNR Am J Neuroradiol Date: 2014-05-29 Impact factor: 3.825
Authors: Ye Yuan; Guangyu Chu; Tingting Gong; Lianze Du; Lizhi Xie; Qinghai Yuan; Qinghe Han Journal: Biomed Res Int Date: 2021-02-04 Impact factor: 3.411